17-HIDROXIPROGESTERONA (17-OHP) - TRIAGEM NEONATAL
ANVISA Registration Number: 80048490105USA DIAGNOSTICA LTDAMONOBIND, INCRisk Class III
Device names
- Risk class
- Class III
Registration details
- Registration Number
- 80048490105
- Process Number
- 25351434132202468
- CNPJ
- 02330159000108
Company information
- Registration Holder
- USA DIAGNOSTICA LTDA
- Manufacturer
- MONOBIND, INC
- Manufacturing Country
- United States
PT: ESTADOS UNIDOS DA AMÉRICA
Dates and status
- Publication Date
- May 12, 2025
- Status
- Active
About this record
Access comprehensive regulatory information for 17-HIDROXIPROGESTERONA (17-OHP) - TRIAGEM NEONATAL in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80048490105 and manufactured by MONOBIND, INC. The registration is held by USA DIAGNOSTICA LTDA with validity until May 12, 2035.
This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.